ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Of relevance, preliminary data revealed that the beneficial effects of pioglitazone on adiponectin levels and hepatic histology in NAFLD patients were reversed after therapy discontinuation, suggesting that long-term therapy with TZDs may be required [144].